Project cooperationUpdated on 9 April 2026
ASPER2
About
ASPER2 is a therapeutic oligonucleotide based on the ESiNAR-X platform, intended for patients with gradually progressive chronic kidney disease accompanied by renal fibrosis.
Status: Finished pre-clinical validation
We are seeking investments and partnerships to support the execution of clinical trials.
Similar opportunities
Project cooperation
Eczacıbaşı Seeking Consortium for HORIZON-HLTH-2027-02-TOOL-01-two-stage
- Other
- Healthcare
- Electronics
- EU projects
- Partner looking for consortium
Hakan Bozcu
Senior Innovation Projects Specialist at Eczacıbaşı Building Products
Bilecik, Türkiye
Partnership
R&D collaboration for pre-clinical assets
Njabulo Skhosana
Co-Founder and CEO at CureRoot
Johannesburg, South Africa
Partnership
Do Youn Chun
Chief Technical Officer at AT-31 BIO Inc.
Daegu, South Korea